Case report of a massive giant ameloblastoma and its management
DOI:
https://doi.org/10.18203/2349-2902.isj20223607Keywords:
Giant Ameloblastoma, Largest reported, Wide resection, Single stage osteocutaneous reconstructionAbstract
Ameloblastoma is a benign odontogenic tumor. It is slow growing, locally aggressive, rare tumor, accounting for 1% of all the jaw tumors. Here, we report a case of a Giant ameloblastoma in a 38-year-old gentleman who presented with a massive tumor of the mandible, possibly the largest reported in literature. The tumor had caused significant facial disfigurement and functional impairment leading to nutritional deficiency, anemia and dehydration induced elevated renal parameters. It was neglected by the patient for over ten years, due to the fear of surgery and financial constraints. Pre-operative evaluation included 3-Dimensional computerized tomographic imaging of the head and neck and optimization of deranged hematological & renal parameters and high blood pressure. Surgical treatment entailed complete tumor resection with adequate margins and microvascular reconstruction with fibular free flap in a single stage. This case of a giant multicystic ameloblastoma of the mandible, possibly the largest of its kind, was managed by complete surgical resection and a simultaneous single stage reconstruction with complete financial aid provided by our institution for the entire treatment. Finally, providing the patient, an acceptable functional, aesthetic, and oncological outcome.
Metrics
References
Connole PW. Tumor of dental origin, Ameloblastoma, Otolaryngol Clin North Am. 1979;12(1):141-4.
Vallicioni J, Loum B, Dassonville O, Poissonnet G, Ettore F, Demard F. Ameloblastomas. Ann Otolaryngol Chir Cervicofac. 2007;124(4):166e71.
Reichart PA, Philipsen HP, Sonner S. Ameloblastoma: biologicalprofileof3677 cases. Eur J Cancer B Oral Oncol. 1995;31(2):86e99.
Michael AN, Eyituoyo MO, Mubarak ME, Olabode VO. Intracranial extension of giant multicystic maxillomandibular ameloblastoma: A case report. Internet J Radiol. 2010;12:1-4.
Agha RA, Borrelli MR, Farwana R, Koshy K, Fowler A, Orgill DP. For the SCARE Group. The SCARE 2018 Statement: Updating Consensus Surgical CAse REport (SCARE) Guidelines, Int J Surg. 2018;60:132-6.
Nagi R, Sahu S, Rakesh N. Molecular and genetic aspects in the etiopatho- genesis of ameloblastoma: an update. J Oral Maxillofac Pathol. 2016;20(3):497e504.
El-Naggar AK, Chan KC, Grandis JR, Takata T, Slootweg PJ. WHO classification of head and neck tumours. WHO/IARC classification of tumours. fourth ed., vol. 9: 2017.
Hunter K, Robinson M. Soames’ & Southam’s Oral Pathology, Oxford University Press, UK, 2018.
Lunardi LV, Fava AS, Martins RH, Homem MGN, Rapoport A, Carvalho MB. Tratamento cirúrgico do ameloblastoma com reconstrução de mandíbula com enxerto de crista ilíaca não vascularizado – estudo de sete casos. Rev Col Bras Cir. 2001;28(1):9-12.
Thompson L. World Health Organization classification of tumours: pathology and genetics of head and neck tumours, Ear Nose Throat J. 2006;85(2):74.
Laborde A, Nicot R, Wojcik T, Ferri J, Raoul G. Ameloblastoma of the jaws: Management and recurrence rate. Euro Annals Otorhinolaryngol Head Neck Dis. 2017;134:7–11.
Carlson ER, Marx RE. The ameloblastoma: primary, curative surgical management. J Oral Maxillofac Surg. 2006;64:484-94.
